新加坡女性HPV疫苗接种策略对HPV相关癌症负担的长期影响:比例多状态生命表模拟
研究采用比例多状态生命表模型模拟新加坡12至100岁女性队列,比较渐进补种程序(15年内将接种覆盖率从15%升至90%,针对17岁及以上未覆盖人群)与假设性HPV消除情景相对于常规基线对宫颈癌和口咽癌负担的长期影响。结果显示渐进补种程序可避免大量癌症病例并获得健康调整生命年,约达到消除情景最大获益的89%,支持新加坡现行国家HPV疫苗接种策略。
要点
- 渐进补种HPV疫苗可显著减少宫颈癌和口咽癌病例及健康调整生命年损失。
- 补种程序获得约89%的假设消除情景最大潜在获益。
- 结果支持新加坡持续开展国家HPV疫苗接种策略。
核心结论
- 针对17岁及以上人群的渐进补种HPV疫苗接种程序可大幅降低新加坡女性未来宫颈癌和口咽癌负担。
- 假设性HPV消除情景代表可达到的获益上限,补种程序实现约89%的最大潜在获益。
研究设计与样本
- 采用比例多状态生命表模型模拟12至100岁女性队列。
- 通过HPV患病率变化推导人群影响分数并应用于基线癌症率来预测未来癌症发病。
- 比较渐进补种程序、假设性HPV消除情景与常规基线三种情景。
主要发现
- 渐进补种程序在队列终身(100年)预计避免164,968例宫颈癌(95% UI:135,721至194,154)和4,007例口咽癌(95% UI:3,036至4,966)。
- 渐进补种程序对应两种癌症合计获得120,919健康调整生命年(95% UI:89,459至150,325)。
- 假设性HPV消除情景预计避免186,375例宫颈癌(95% UI:157,662至214,880)和4,518例口咽癌(95% UI:3,595至5,465),获得136,521健康调整生命年(95% UI:106,349至166,457)。
关键数值与推荐
- 渐进补种程序:15年内将接种覆盖率从基线15%逐步升至90%,针对17岁及以上未受2019年学校项目覆盖的队列。
- 假设性HPV消除情景同样在15年内逐步引入。
临床怎么用
- 支持将17岁及以上未覆盖人群的渐进补种HPV疫苗接种作为国家策略持续推行。
- 补种程序可视为接近消除情景上限的高效干预选择。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To project the long-term health impact, measured in cancer cases averted and Health-Adjusted Life Years (HALYs) gained, of different Human Papillomavirus (HPV) vaccination strategies on the burden of cervical and oropharyngeal cancers in the female population of Singapore. DESIGN: We developed a Proportional Multistate Life Table (PMSLT) model to simulate a cohort of females from age 12 to 100. The model projects future cancer incidence by applying population impact fractions, derived from changes in HPV prevalence, to baseline cancer rates. We compared two intervention scenarios against a "Business as Usual" baseline: (1) a gradual catch-up program modelling a phased increase in vaccination coverage from a baseline of 15% to 90% over 15 years, targeting cohorts aged 17 years and above who were not covered by Singapore's 2019 school-based program, and (2) a hypothetical "HPV eradication" scenario, also phased in over 15 years. RESULTS: The gradual catch-up program was projected to avert a mean of 164,968 (95% UI: 135,721 to 194,154) cervical cancer cases and 4007 (95% UI: 3036 - 4966) oropharyngeal cancer cases over the cohort's lifetime (100 years). This corresponds to a total gain of 120,919 (95% UI: 89,459 - 150,325) HALYs across both cancers. The hypothetical HPV eradication scenario would avert 186,375 (95% UI: 157,662- 214,880) cervical cancer cases and 4518 (95% UI: 3595 to 5465) oropharyngeal cancer cases, gaining 136,521 (95% UI: 106,349 to 166,457) HALYs. CONCLUSION: A gradual catch-up HPV vaccination program targeting cohorts aged 17 years and above can substantially reduce the future burden of cervical and oropharyngeal cancers in Singapore. A hypothetical HPV Eradication scenario represents the upper bound of achievable benefit, and the catch-up program achieves approximately 89% of this maximum potential gain. These findings strongly support Singapore's ongoing national HPV vaccination strategy.
引用
- Cooray U, Singh A, Peres MA, et al. Long-term impacts of HPV vaccination strategies on HPV related Cancer burden among Singaporean female population: A prospective simulation using proportional multistate lifetables. Vaccine. 2026. PMID: 41905061. doi:10.1016/j.vaccine.2026.128513
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。